Market Report

Market Report by Email

If you would like to receive the daily Market Report by email please fill out your name and email address in the sign-up form below and you will be added to our mailing list.

* indicates required

Please select all the ways you would like to hear from Ramsey Crookall:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our email marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.

Learn more about Mailchimp's privacy practices here.

Tuesday,30 April 2024 at 15:57

UK and European markets were lower after a flurry of earnings and key data points were released.

The yen dropped against the dollar, giving up some of its sharp gains the previous day sparked by suspected intervention by Japanese authorities.

Oil edged down after Israel-Hamas ceasefire talks in Cairo helped quell market fears of an expanded conflict in the Middle East.

Gold fell as market focus shifted to the Federal Reserve’s policy meeting.

Shares in Eli Lilly jumped on Wall Street after the American pharma giant beat quarterly profit forecasts and hiked its full-year sales guidance by $2bn, helped by surging demand for its weight-loss drug Zepbound.

The upgrade was driven by strong performances of Zepbound and diabetes drug Mounjaro along with greater visibility into production expansion for the remainder of the year, with both drugs currently in short supply in the US market. 

At the close
FTSE 100 8,144 (-0.04%)
FTSE 250 19,965 (-0.59%)
DAX 17,921 (-1.08%)
At 16:50
Dow Jones 38,079 (-0.80%)
S&P 500 5,081 (-0.67%)
NASDAQ 15,860 (-0.77%)
Fixed Income
UK 10-YR YIELD 4.347
Exchange Rates
GBP/USD 1.252
GBP/EUR 1.170
Gold $2,296 (-1.64%)
Brent $86.19 (-1.21%)
Important - No news or research item should be construed as a recommendation to trade. The inclusion of securities within this report does not necessarily imply their suitability for individual portfolios or situations in respect of which further advice should be sought. Information contained in this report has been compiled from sources believed to be reliable but is not warranted to be accurate or complete.

We use cookies to improve your experience on our website.
By continuing to browse, you agree to our use of cookies. Cookie Policy

Members of the London Stock Exchange and PIMFA | Licensed by the Isle of Man Financial Services Authority (IoMFSA) Registered Office: Ramsey Crookall and Co. Ltd., 38/42 Athol Street, Douglas, Isle of Man, IM1 1QH
Copyright © 2023 - Ramsey Crookall & Co. Ltd
Building Personal Finance Futures London Stock Exchange